首页> 外文会议>Annual Computers in Cardiology Conference >Principal component analysis of the QRS complex during diagnostic ajmaline test for suspected Brugada Syndrome
【24h】

Principal component analysis of the QRS complex during diagnostic ajmaline test for suspected Brugada Syndrome

机译:诊断Ajmaline试验中QRS复合物的主要成分分析疑似Brugada综合征

获取原文

摘要

We used principal component analysis (PCA) of the QRS complex to assess depolarisation heterogeity during ajmaline test in 96 patients with suspected Brugada Syndrome (BS). PCA was performed on 15-lead ECGs (12 leads +V1, V2 and V3 from 3rd intercostal space, V1h to V3h using a) V1, V2 and V3 (QRS-PCAstand), b) V1h, V2h and V3h (QRS-PCAhigh), and c) V1 to V3, V1h to V3h (QRS-PCAtotal). Among patients with positive tests (n=23), those with symptoms (n=6) had higher QRS-PCAhigh before (p=0.003) and during maximum drug effect (p=0.001) than those without symptoms (n=17). Following ajmaline, QRS-PCA decreased significantly in patients with negative (n=73) (p=0.00004), but not in those with positive tests (p=0.098). Symptomatic patients with non-diagnostic resting ECGs have increased depolarisation heterogeneity. PCA could detect depolarisation heterogeity and thus help the diagnosis and risk stratification of patients with BS.
机译:我们使用了QRS复合物的主成分分析(PCA)来评估96例疑似Brugada综合征(BS)的Ajmaline试验期间的去偏振异形。 PCA在15-铅ECG(12个引线+ V1,V2和V3,使用A)V1,V2和V3(QRS-PCAST​​AND),B)V1H ,V2H和V3H(QRS-PCAHIGH)和C)V1至V3,V1H至V3H(QRS-PCATOTAL)。在阳性试验(n = 23)的患者中,患有症状(n = 6)的患者(p = 0.003)和最大药物效果(p = 0.001),而不是没有症状的那些(n = 17)。在Ajmaline之后,QRS-PCA在阴性(n = 73)的患者患者中显着降低(p = 0.00004),但不在阳性测试的患者中(p = 0.098)。具有非诊断休息ECG的症状患者具有增加的脱极性异质性。 PCA可以检测到Depolarisation Fentigeity,从而有助于BS患者的诊断和风险分层。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号